Overview
Mark Leibowitz is a primary care provider, practicing in Internal Medicine in Long Beach, California.
His clinical expertise encompasses Maturity Onset Diabetes of the Young, Nonalcoholic Steatohepatitis (NASH), and Non-Alcoholic Fatty Liver Disease.
He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 12 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
2600 Redondo Ave Ste 500, Long Beach, CA 90806
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Cancer Center Of Southern California
Sant Chawla is an Internal Medicine provider practicing medicine in Santa Monica, California. He has been practicing medicine for over 51 years. Dr. Chawla is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Myxoid Liposarcoma. Dr. Chawla is board certified in American Board Internal Medicine.
The Regents Of The University Of California
Charles Bernstein is an Internal Medicine provider practicing medicine in Los Angeles, California. Dr. Bernstein is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Crohn's Disease, Colitis, Colonoscopy, and Endoscopy.
Harbor-UCLA Nephrology
from Wikipedia: https://en.wikipedia.org/wiki/Kamyar_Kalantar-ZadehEducationKalantar-Zadeh received his education in medicine from the University of Bochum and University of Bonn (Germany) and his M.D. degree from the University of Erlangen-Nuremberg (Germany).[1] In addition, he obtained a master's degree in public health (Master of Public Health, MPH) and a PhD in epidemiology from the University of California, Berkeley.[1] He is a practicing triple board certified physician specialist in internal medicine, pediatrics, and nephrology.[1] Kalantar-Zadeh completed his residency at the State University of New York and his nephrology fellowship at the University of California, San Francisco.[1]CareerKalantar-Zadeh is a professor of medicine at the David Geffen School of Medicine at UCLA and based at the Lundquist Institute for Biomedical Innovation at Harbor–UCLA Medical Center (2000-2012, and since 2023), where he worked with his former mentor Joel D. Kopple and served as the founding director of the Harold Simmons Center for Chronic Disease Research and Epidemiology. During 2012-2022 Kalantar-Zadeh was in the University of California, Irvine School of Medicine as a tenured professor of medicine, pediatrics, public health, and Nursing Sciences, and chief of Nephrology,[1] and the UC Irvine Medical Center. He also serves as a part-time staff physician at Tibor-Rubin VA Medical center in Long Beach, California, under the Veterans Health Administration. Kalantar-Zadeh has r. Dr. Kalantar-Zadeh is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Hypertension, High Potassium Level, Kidney Transplant, and Nephrectomy. Dr. Kalantar-Zadeh is board certified in Interal Medicine, Nephrology, and Pediatrics. Dr. Kalantar-Zadeh is currently accepting new patients.
Frequently Asked Questions about Dr. Mark Leibowitz
How do I make an appointment with Dr. Mark Leibowitz?
You can book an appointment with Dr. Mark Leibowitz by calling their office at 562-304-1742. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Leibowitz a top-rated expert for Maturity Onset Diabetes of the Young?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Leibowitz is classified as an Experienced expert for Maturity Onset Diabetes of the Young, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Leibowitz specialize in?
While Dr. Mark Leibowitz is a Internal Medicine, they have specific expertise in Maturity Onset Diabetes of the Young, Nonalcoholic Steatohepatitis (NASH), and Non-Alcoholic Fatty Liver Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Mark Leibowitz participate in research or clinical trials?
Yes. Dr. Mark Leibowitz has published 4 articles and abstracts on conditions like Maturity Onset Diabetes of the Young. You can view a list of Dr. Mark Leibowitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Leibowitz accept my insurance?
Dr. Mark Leibowitz accepts most major insurance plans, including Blue Cross Blue Shield and Medicaid. We recommend calling the office directly at 562-304-1742 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Maturity Onset Diabetes of the YoungDr. Leibowitz isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Non-Alcoholic Fatty Liver DiseaseDr. Leibowitz isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.
- Nonalcoholic Steatohepatitis (NASH)Dr. Leibowitz isExperienced. Learn about Nonalcoholic Steatohepatitis (NASH).
